GPcardio Industry Roundtable

Connecting innovation with clinical practice to improve patient outcomes.

The GPcardio Industry Roundtable is a strategic initiative that brings together GPcardio and leading innovative pharmaceutical and life sciences companies with a shared ambition: to improve the prevention, early detection and management of cardiovascular, renal and metabolic (CRM) diseases in primary care.

As the burden of these interconnected conditions continues to grow, there is an increasing need to bridge the gap between scientific innovation, clinical guidelines and everyday patient care. Primary care plays a pivotal role in this process, offering unique opportunities for earlier intervention, integrated disease management and improved long-term health outcomes.

A Platform for Collaboration and Innovation

The GPcardio Industry Roundtable provides a collaborative forum for meaningful dialogue between industry, primary care professionals, scientific experts and other healthcare stakeholders.

Through this initiative, we aim to:

• Accelerate the translation of innovation into clinical practice by connecting emerging scientific evidence, new therapeutic approaches and innovative technologies with the realities of primary care.
• Identify unmet needs and barriers to implementation in cardiovascular, renal and metabolic disease prevention and management.
• Support education and knowledge exchange to help healthcare professionals implement evidence-based strategies and improve patient outcomes.
• Explore opportunities for joint initiatives that promote earlier diagnosis, better risk assessment, integrated care and more effective disease management.
• Strengthen collaboration between industry and primary care, ensuring that innovation addresses real-world clinical challenges and patient needs.

From Scientific Innovation to Real-World Impact

The GPcardio Industry Roundtable is built on the belief that meaningful improvements in patient outcomes require collaboration across the healthcare ecosystem.

By combining the scientific expertise and innovative capabilities of the pharmaceutical industry with GPcardio's international primary care network, educational platforms and clinical expertise, we seek to accelerate the adoption of effective, evidence-based interventions.

Our focus extends beyond individual therapies to the broader challenge of improving cardiovascular, renal and metabolic health through prevention, early intervention and integrated care.

Independent, Transparent and Purpose-Driven

The GPcardio Industry Roundtable operates within a framework of scientific independence, transparency and shared commitment to improving healthcare.

Collaboration with industry is designed to encourage constructive dialogue and support educational and scientific initiatives while safeguarding the independence of clinical content, professional recommendations and educational activities.

Current Industry Round Table Partners

• Viatris
• AstraZeneca
• Boehringer Ingelheim
• Daiichi Sankyo

Join the GPcardio Industry Roundtable

We welcome innovative pharmaceutical and life sciences companies that share our commitment to advancing cardiovascular, renal and metabolic health in primary care.

Together, we can bridge the gap between innovation and implementation — turning scientific progress into better care for patients.